<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00960817</url>
  </required_header>
  <id_info>
    <org_study_id>HYMC 02/2009</org_study_id>
    <nct_id>NCT00960817</nct_id>
  </id_info>
  <brief_title>&quot;Normal Coronary Artery&quot; With Slow Flow Improved by Adenosine Injection, Dipyridamole Treatment and Clinical Follow-up</brief_title>
  <official_title>&quot;Normal Coronary Artery&quot; With Slow Flow Improved by Adenosine Injection, Dipyridamole Treatment and Clinical Follow-up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hillel Yaffe Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hillel Yaffe Medical Center</source>
  <brief_summary>
    <textblock>
      The investigators will investigate patients undergoing coronary angiography with normal
      coronary but slow blood flow that was normalized after adenosine injection into the coronary
      artery. The investigators believe that they have small vessel coronary disease which is the
      initial presentation of coronary disease prior to anatomical narrowing. To alleviate this
      phenomenon the investigators intend to examine the long-term clinical response of these
      patients to treatment with dipyridamole, a well-known medication with almost no side-effects
      that increases the level of adenosine in the tissue.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Alleviation of chest pain</measure>
    <time_frame>Two years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Coronary Angiography</condition>
  <arm_group>
    <arm_group_label>1. Routine treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2. Dipyridamole treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group that receives Dipyridamole treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Statin, aspirin</intervention_name>
    <arm_group_label>1. Routine treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dipyridamole</intervention_name>
    <arm_group_label>2. Dipyridamole treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing coronary angiography and who have normal coronary artery with slow
             blood flow that normalized with adenosine injection into the coronary artery

        Exclusion Criteria:

          -  Significant coronary disease

          -  Unstable patients

          -  Patients with known sensitivity to dipyridamole
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hillel Yaffe Medical Center</name>
      <address>
        <city>Hadera</city>
        <zip>38100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Aaron Frimerman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2009</study_first_submitted>
  <study_first_submitted_qc>August 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2009</study_first_posted>
  <last_update_submitted>August 17, 2009</last_update_submitted>
  <last_update_submitted_qc>August 17, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 18, 2009</last_update_posted>
  <responsible_party>
    <name_title>Aaron Frimerman, MD</name_title>
    <organization>Hillel Yaffe Medical Center</organization>
  </responsible_party>
  <keyword>Normal coronary artery with slow blood flow</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenosine</mesh_term>
    <mesh_term>Dipyridamole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

